AMLX vs AWK
Amylyx Pharmaceuticals Inc (AMLX) versus American Water Works (AWK) — a side-by-side from cached financials, not a winner call.
Amylyx Pharmaceuticals Inc (AMLX) is a biotechnology company listed on US.
American Water Works (AWK) is a utilities - regulated water company listed on US.
Latest reported AMLX revenue for 2024-12-31 was $87.4M. Net income was -$301.7M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AMLX currently screens at market cap $561.6M.
Latest reported AWK revenue for 2024-12-31 was $4.65B. Net income was $239.0M. Revenue was up 10.3% from 2023-12-31 to 2024-12-31. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
AMLX currently screens at market cap $561.6M. AWK currently screens at market cap $24.31B and trailing P/E 22.1.
Not investment advice. Open the AMLX and AWK stock pages for the full models.
Not investment advice.